Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide as Adjuvant for Erosive Reflux Esophagitis
NCT02755753Phase 4Completed
- Start
- Jan 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of rebamipide in reflux esophagitis. Started Jan 2014; status: completed.
02
Drugs
rebamipide
03
Conditions
reflux esophagitis
Beyond the preview
Go deeper on NCT02755753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02755753.